Use of bi-aryl meta-pyrimidine inhibitors of kinases
US8138199B2 · kind B2 · utility
39Cited by
69References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2008 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Apr 27, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides biaryl meta-pyrimidine compounds having the general structure (A). The pyrimidine compounds of the invention are capable of inhibiting kinases, such as members of the Jak kinase family, and various other specific receptor and non-receptor kinases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.